Interestingly, in ovarian cancer, increased mitochondrial ROS generation and activation of the AKT/mTOR signaling pathway upregulate SREBP2 expression, thereby promoting cholesterol biosynthesis 151. This evidence concerns the gene SREBF2 and ovarian cancer.